Here's the live share price of Hester Biosciences along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Over the last 5 years, the share price of Hester Biosciences has gained 4.37% CAGR. Over the past year, the corresponding return has been -16.47%.
Hester Biosciences’s current P/E of 46.39x helps give context to how the market is valuing the stock based on recent earnings and growth expectations. Check out if this stock is part of our Highest YOY Quarterly profit growth Screener.
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
---|---|---|---|---|---|---|---|
Hester Biosciences | -2.71 | 6.39 | 12.53 | 44.38 | -16.47 | -0.59 | 4.37 |
Sun Pharmaceutical Industries | 1.67 | -0.74 | -1.73 | -5.03 | -13.17 | 22.82 | 25.92 |
Divi's Laboratories | 0.43 | -1.79 | -7.35 | 6.82 | 11.03 | 18.72 | 13.53 |
Cipla | -0.28 | -0.33 | 3.71 | 4.44 | -6.69 | 14.64 | 15.70 |
Torrent Pharmaceuticals | -1.10 | -2.72 | 9.28 | 16.13 | 2.96 | 33.93 | 20.15 |
Dr. Reddy's Laboratories | 0.52 | 3.73 | -0.61 | 13.95 | -1.15 | 16.94 | 6.31 |
Mankind Pharma | -1.64 | 3.88 | 9.08 | 18.13 | 4.58 | 21.69 | 12.50 |
Zydus Lifesciences | -0.57 | 4.75 | 7.77 | 15.69 | -6.93 | 42.16 | 21.26 |
Lupin | 2.60 | 3.02 | 4.40 | 1.91 | -10.64 | 46.79 | 14.35 |
Abbott India | -0.85 | -4.90 | -2.43 | 2.84 | 7.47 | 21.30 | 13.54 |
Alkem Laboratories | 2.66 | 2.12 | 13.49 | 13.40 | -12.19 | 18.95 | 13.98 |
Aurobindo Pharma | 4.16 | 0.37 | -1.39 | -1.69 | -29.51 | 28.16 | 6.17 |
Glenmark Pharmaceuticals | -4.41 | 3.19 | 23.20 | 42.38 | 18.91 | 76.49 | 32.85 |
Anthem Biosciences | 5.89 | 7.84 | 18.23 | 18.23 | 18.23 | 5.74 | 3.41 |
Laurus Labs | -0.51 | 3.09 | 35.04 | 53.43 | 77.96 | 20.69 | 25.98 |
Biocon | -2.53 | -2.59 | 0.62 | 6.24 | -5.53 | 6.94 | -4.31 |
GlaxoSmithKline Pharmaceuticals | -3.46 | -1.94 | -15.89 | 1.60 | -2.30 | 24.69 | 9.19 |
Cohance Lifesciences | -2.30 | 7.56 | -2.57 | -14.86 | -16.33 | 28.11 | 20.30 |
Ipca Laboratories | -0.07 | -5.18 | -3.23 | -0.19 | -9.85 | 15.26 | 4.10 |
Gland Pharma | 4.39 | 0.78 | 13.75 | 27.92 | 7.57 | -3.99 | 1.77 |
Over the last one year, Hester Biosciences has declined 16.47% compared to peers like Sun Pharmaceutical Industries (-13.17%), Divi's Laboratories (11.03%), Cipla (-6.69%). From a 5 year perspective, Hester Biosciences has underperformed peers relative to Sun Pharmaceutical Industries (25.92%) and Divi's Laboratories (13.53%).
Day | SMA | EMA |
---|---|---|
5 | 2,093.56 | 2,075.51 |
10 | 2,094.24 | 2,078.91 |
20 | 2,062.4 | 2,059.18 |
50 | 1,966.07 | 1,989.04 |
100 | 1,888.37 | 1,934.26 |
200 | 1,923.07 | 1,941.4 |
In the latest quarter, Hester Biosciences remained same as its previous close in promoter holding, while DII stake unchanged at 0.02%, FII holding fell to 0.51%, and public shareholding moved up to 45.73% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
---|---|---|---|
Motilal Oswal BSE Healthcare ETF | 92 | 0.06 | 0.02 |
Date Time | Announcement |
---|---|
Aug 13, 2025, 7:47 PM IST | Hester Biosciences L - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report |
Aug 13, 2025, 7:44 PM IST | Hester Biosciences L - Shareholder Meeting / Postal Ballot-Outcome of AGM |
Aug 05, 2025, 12:33 AM IST | Hester Biosciences L - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome |
Aug 01, 2025, 9:56 PM IST | Hester Biosciences L - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome |
Aug 01, 2025, 6:03 AM IST | Hester Biosciences L - Announcement under Regulation 30 (LODR)-Press Release / Media Release |
Hester Biosciences Ltd. is a Public Limited Listed company incorporated on 29/04/1987 and has its registered office in the State of Gujarat, India. Company's Corporate Identification Number(CIN) is L99999GJ1987PLC022333 and registration number is 022333. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company's Total Operating Revenue is Rs. 286.47 Cr. and Equity Capital is Rs. 8.51 Cr. for the Year ended 31/03/2025.
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Hester Biosciences is ₹2,050.00 as on Sep 17, 2025.
The Hester Biosciences is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
The market cap of Hester Biosciences is ₹1,743.91 Cr as on Sep 17, 2025.
Today’s highest and lowest price of Hester Biosciences are ₹2,063.20 and ₹2,044.00.
The 52-week high/low is the highest and lowest price at which Hester Biosciences stock has traded in the past 52-week or nearly a year. The 52-week high of Hester Biosciences is ₹2,780.00 and 52-week low of Hester Biosciences is ₹1,246.75 as on Sep 17, 2025.
The Hester Biosciences has shown returns of -0.42% over the past day, 6.39% for the past month, 12.53% over 3 months, -16.47% over 1 year, -0.59% across 3 years, and 4.37% over 5 years.
P/E ratio of and PB ratio of Hester Biosciences are 46.39 and 5.55 on Sep 17, 2025. While the company gives a dividend yield of 0.34 per annum.